Eight lots of a certain blood pressure medication have been recalled after testing showed the medication contained trace amounts of a cancer-causing material.

The Baltimore company is pulling all batches of 75mg, 150mg and 300mg Irbesartan and 150mg/12.5mg and 300mg/12.5 mg Irbesartan and Hydrochlorothiazide.

(KPLC) - Prinston Pharmaceutical, Inc., dba Solco Healthcare, LLC., has initiated a voluntary recall of one lot of Irbesartan and seven lots of Irbesartan HCTZ Tablets to the consumer level due to the ...

Lupin Pharmaceuticals is recalling all batches of irbesartan tablets USP 75 mg, 150 mg, and 300 mg and irbesartan and hydrochlorothiazide (HCTZ) tablets USP 150 mg/12.5 mg and 300 mg/12.5 mg ...

All batches of irbesartan tablets USP 75mg, 150mg and 300mg; All batches of irbesartan and hydrochlorothiazide tablets USP, 150mg/12.5mg and 300mg/12.5mg; ...

The Baltimore company is pulling all batches of 75mg, 150mg and 300mg Irbesartan and 150mg/12.5mg and 300mg/12.5 mg Irbesartan and Hydrochlorothiazide.

The Baltimore company is pulling all batches of 75mg, 150mg and 300mg Irbesartan and 150mg/12.5mg and 300mg/12.5 mg Irbesartan and Hydrochlorothiazide.

The Baltimore company is pulling all batches of 75mg, 150mg and 300mg Irbesartan and 150mg/12.5mg and 300mg/12.5 mg Irbesartan and Hydrochlorothiazide.

The Baltimore company is pulling all batches of 75mg, 150mg and 300mg Irbesartan and 150mg/12.5mg and 300mg/12.5 mg Irbesartan and Hydrochlorothiazide.